絞り込み

18370

広告

Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment.

著者 Reinhold T , Brüggenjürgen B
Allergo J Int.2017 ; 26(1):7-15.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (13view , 0users)
Whereas specific immunotherapy (SIT) has already been shown to be cost-effective in the treatment of allergic rhinitis compared with symptomatic treatment, only a small number of investigations have compared sublingual (SLIT) and subcutaneous (SCIT) immunotherapeutic approaches. This analysis discusses the cost-effectiveness of SCIT compared with SLIT and a symptomatic treatment modality. At the same time, particular attention is paid to preparation-specific characteristics.
PMID: 28217432 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード